EQNSX
Price
$21.69
Change
+$0.02 (+0.09%)
Updated
Jun 5 closing price
Net Assets
623.38M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

EQNSX vs RMEBX

Header iconEQNSX vs RMEBX Comparison
Open Charts EQNSX vs RMEBXBanner chart's image
MFS Equity Income R2
Price$21.69
Change+$0.02 (+0.09%)
VolumeN/A
Net Assets623.38M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
EQNSX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EQNSX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNSX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. EQNSX (623M). EQNSX pays higher dividends than RMEBX: EQNSX (1.76) vs RMEBX (1.16). EQNSX was incepted earlier than RMEBX: EQNSX (13 years) vs RMEBX (11 years). EQNSX (1.20) is less costly to investors than RMEBX (1.07). EQNSX is a more actively managed with annual turnover of: 45.00 vs. RMEBX (31.00). EQNSX has a lower initial minimum investment than RMEBX: EQNSX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. EQNSX (2.56). EQNSX (52.17) and RMEBX (49.85) have equivalent 5 years return.
EQNSXRMEBXEQNSX / RMEBX
Total Expense Ratio1.141.07107%
Annual Report Gross Expense Ratio1.201.07112%
Fund Existence13 years11 years-
Gain YTD3.3685.34963%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets623M105B1%
Annual Yield % from dividends1.761.16152%
Returns for 1 year2.568.3031%
Returns for 3 years19.2617.96107%
Returns for 5 years52.1749.85105%
Returns for 10 years87.9768.21129%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA